Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure—COMET
- 28 February 2005
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 149 (2), 370-376
- https://doi.org/10.1016/j.ahj.2004.10.002
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Do β-blockers prolong survival in heart failure only by inhibiting the β1-receptor? A perspective on the results of the COMET trialJournal of Cardiac Failure, 2003
- Effect of Carvedilol on the Morbidity of Patients With Severe Chronic Heart FailureCirculation, 2002
- Endothelial AdrenoceptorsJournal of Cardiovascular Pharmacology, 2001
- Effects Of Digoxin, Furosemide, Enalaprilat And Metoprolol On Endothelial Function In Young Normotensive SubjectsClinical and Experimental Pharmacology and Physiology, 2001
- The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trialThe Lancet, 1999
- 3-year follow-up of patients randomised in the metoprolol in dilated cardiomyopathy trialThe Lancet, 1998
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- Beneficial effects of metoprolol in idiopathic dilated cardiomyopathyThe Lancet, 1993
- Xamoterol in severe heart failureThe Lancet, 1990
- Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy.Heart, 1975